SecSonar.com

Elevance Health Inc. (ELV)

Elevance Health Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Elevance Health Inc. (ELV) is a Medical - Healthcare Plans company based in US with a market capitalization of $85.6B. Revenue grew 12.6% year-over-year and the company generated $3.2B in free cash flow. This page tracks ELV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 104.2K employees · IPO Oct 30, 2001

Valuation

Valuation & price

$392.68 · as of May 17, 2026 · -7.5% vs 52w high

15.4

P/E ratio

Latest-FY diluted EPS

1.95

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$424$350$275Jul 25Dec 25Jun 26Jul 7, 25$346.88Jul 9, 25$346.36Jul 11, 25$340.67Jul 15, 25$336.21Jul 17, 25$302.45Jul 21, 25$276.45Jul 23, 25$296.60Jul 25, 25$289.10Jul 29, 25$288.73Jul 31, 25$283.08Aug 4, 25$274.93Aug 6, 25$276.30Aug 8, 25$293.99Aug 12, 25$292.48Aug 14, 25$295.43Aug 18, 25$309.32Aug 20, 25$310.00Aug 22, 25$316.55Aug 26, 25$310.03Aug 28, 25$310.41Sep 3, 25$321.59Sep 5, 25$313.64Sep 9, 25$315.09Sep 11, 25$314.89Sep 15, 25$306.91Sep 17, 25$308.48Sep 19, 25$313.71Sep 23, 25$323.73Sep 25, 25$316.70Sep 29, 25$319.69Oct 1, 25$332.66Oct 3, 25$350.50Oct 7, 25$357.49Oct 9, 25$358.13Oct 13, 25$351.42Oct 15, 25$349.49Oct 17, 25$348.77Oct 21, 25$349.75Oct 23, 25$346.28Oct 27, 25$342.49Oct 30, 25$321.95Nov 3, 25$313.19Nov 5, 25$318.08Nov 7, 25$317.78Nov 11, 25$315.25Nov 13, 25$328.28Nov 17, 25$330.91Nov 19, 25$316.37Nov 21, 25$321.73Nov 25, 25$336.27Nov 28, 25$338.26Dec 2, 25$330.92Dec 4, 25$333.49Dec 8, 25$330.61Dec 10, 25$341.04Dec 12, 25$359.07Dec 16, 25$351.90Dec 18, 25$344.60Dec 22, 25$344.27Dec 24, 25$343.30Dec 29, 25$348.38Jan 2, 26$354.25Jan 6, 26$371.37Jan 8, 26$374.77Jan 12, 26$374.97Jan 14, 26$372.84Jan 16, 26$374.87Jan 21, 26$369.88Jan 23, 26$371.06Jan 27, 26$322.92Jan 29, 26$346.98Feb 2, 26$341.83Feb 4, 26$340.60Feb 6, 26$338.98Feb 10, 26$325.64Feb 12, 26$336.04Feb 17, 26$344.78Feb 19, 26$348.18Feb 23, 26$335.87Feb 25, 26$330.51Mar 2, 26$294.07Mar 4, 26$291.45Mar 6, 26$289.64Mar 10, 26$282.68Mar 12, 26$287.89Mar 16, 26$292.07Mar 18, 26$294.95Mar 20, 26$291.48Mar 24, 26$290.33Mar 26, 26$294.25Mar 30, 26$284.79Apr 1, 26$298.50Apr 6, 26$302.61Apr 8, 26$318.23Apr 10, 26$311.53Apr 14, 26$313.35Apr 16, 26$315.82Apr 20, 26$319.36Apr 22, 26$328.20Apr 24, 26$344.76Apr 28, 26$362.74May 1, 26$372.68May 5, 26$369.07May 7, 26$372.92May 11, 26$381.75May 13, 26$399.64May 15, 26$392.68May 19, 26$402.27May 21, 26$389.82May 26, 26$387.85May 28, 26$392.75Jun 1, 26$402.66Jun 3, 26$391.27Jun 5, 26$415.53Jun 9, 26$424.43Jun 11, 26$399.18Jun 15, 26$401.89Jun 17, 26$391.27Jun 22, 26$394.82Jun 26, 26$395.18
$274.6652-week range$424.43
Loading valuation history…

Fundamentals

Key fundamentals

$85.6B

Market cap

12.6%

Revenue growth (YoY)

25.6%

Gross margin

$3.2B

Free cash flow (USD)

$23.7B

Net debt

-4.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$85.0BFY 2017$90.0BFY 2018$92.1BFY 2019$104.2BFY 2020$121.9BFY 2021$138.6BFY 2022$156.6BFY 2023$171.3BFY 2024$176.8BFY 2025$199.1B
$85B$199.1B

Free cash flow by year

2016 → 2025

FY 2016$2.6BFY 2017$3.4BFY 2018$2.6BFY 2019$5.0BFY 2020$9.7BFY 2021$7.3BFY 2022$7.2BFY 2023$6.8BFY 2024$4.6BFY 2025$3.2B
$2.6B$3.2B

Gross margin by year

2021 → 2025

FY 202126.0%FY 202225.5%FY 202327.4%FY 202427.9%FY 202525.6%
26.0%25.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

3

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 22, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $149KPenczek Ronald W · CAO & Controller · $148.8KJun 15, 2026Filing
  • Insider sellInsider Sell $61KDixon Robert L JR · Director · $60.7KJun 12, 2026Filing
  • 8-K eventEarnings Guidance ReaffirmedJun 10, 2026Filing
  • Insider sellInsider Sell $617KPenczek Ronald W · CAO & Controller · $617.2KMay 20, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 13, 2026Filing
  • 8-K eventEarnings ReleaseApr 22, 2026Filing
  • Quarterly report10-Q FiledApr 22, 2026Filing

Questions

Frequently asked questions

What is Elevance Health Inc.'s market cap?

Elevance Health Inc. (ELV) has a market capitalization of $85.6B.

What is ELV's P/E ratio?

ELV trades at a price-to-earnings ratio of 15.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ELV's price-to-book (P/B) ratio?

ELV trades at 1.95 times book value per share.

Are insiders buying ELV stock?

SEC Form 4 filings show no open-market insider buys at Elevance Health Inc. in the last 90 days (3 sells).

Same arena

Related companies in Medical - Healthcare Plans

CI

Cigna Corporation

$73.7B

CVS

CVS Health Corporation

$116.5B

HUM

Humana Inc.

$36.8B

CNC

Centene Corporation

$29.2B

MOH

Molina Healthcare, Inc.

$9.1B

OSCR

Oscar Health, Inc.

$5.8B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.